Status:
RECRUITING
Natural History Study of Patients With Excess Androgen
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Congenital Adrenal Hyperplasia (CAH)
Familial Male-Limited Precocious Puberty (FMPP)
Eligibility:
All Genders
1-99 years
Brief Summary
This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe pro...
Detailed Description
Study Description: Androgen excess in childhood results in pseudoprecocious puberty, accelerated childhood growth with premature epiphyseal fusion, adult short stature, and unknown metabolic and psyc...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Males, ages 0 - 99 with known or suspected FMPP or
- Patients (males and females, ages 0 - 99) with known or suspected (based on hormonal, clinical and/or genetic testing) CAH of any type.
- Patients with excess androgen of unknown etiology or
- Relatives of patients in this protocol.
- EXCLUSION CRITERIA:
- Females with isolated polycystic ovary syndrome. If, following a diagnostic work-up, a patient is determined to have PCOS as the only cause of her hyperandrogenism; she will no longer be followed on this protocol.
- Patients with significant non-endocrine medical conditions.
- Females who are pregnant at the time of initial enrollment.
Exclusion
Key Trial Info
Start Date :
January 2 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00250159
Start Date
January 2 2006
Last Update
January 5 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
2
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892